Advertisement
+ News Categories + Corporate Categories + Report Categories

NEXT ARTICLE

O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release

05:05 EST 4 Feb 2012 | Nature Publishing

O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine releaseThe protein kinase TAK1 plays an important role in pro-inflammatory cytokine signalling. Interleukin-1- and osmotic stress-induced O-GlcNAcylation of its regulatory subunit TAB1 is requi..

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release

Nature Publishing

 Channels 21 Associated Channels :: Search

  • Soluble cytokine receptors

  • Synthesis and Release of Thyroid Hormones

  • Immunocytokines

    Although the human cytokines interleukin-2 (IL-2) and tumor necrosis factor (TNF) alpha are approved marketed for tumor therapy, their use is rather limited due to severe systemic side effects. Targ...

  • Immunocytokines

    Although the human cytokines interleukin-2 (IL-2) and tumor necrosis factor (TNF) alpha are approved marketed for tumor therapy, their use is rather limited due to severe systemic side effects. Targ...

  • Infectious Uveitis

    Uveitis may be caused by infectious or non-infectious disorders. Although most cases of uveitis are considered to be immune-mediated disorders, certain forms of uveitis are caused by infectious agen...

  • Drug Delivery - news, views, blogs

    Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  Drug delivery technologies are patent protected formulat...

  • Cytotoxic lymphocyte associated molecule 4 CTLA 4 CD152

    Cytotoxic lymphocyte-associated molecule-4 (CTLA-4, CD152) is a member of the CD28 receptor family which is expressed on the surface of Helper T cells. CTLA-4 is similar to the T-cell costimulatory pr...

  • CD22 Antibodies

    Anti-CD22 antibody-based constructs used to treat B-cell mediated malignancies and rheumatoid arthritis.

  • CD19 Antagonists

    Anti-CD19 antibody-based constructs used to treat B-cell mediated malignancies and rheumatoid arthritis.

  • Sphingosine 1 Phosphate S1P

    Sphingosine-1-phospate (S1P) is a phospholipid released by platelets, mast and other cells. It is now known that S1P stimulates at least five different G-protein coupled receptors (GPCRs): S1P1, S1P2,...

Associated Content for this Article